(Q85645778)
Statements
Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) (English)
Lars Hvilsted Rasmussen
scientific article published on 01 July 2015